Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Clinical trial NCT00613223 · COMPLETED
Trial details
- NCT number
- NCT00613223
- Sponsor
- Annick Desjardins
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2010-10-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.